| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |